Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the ...

If you weigh a little more after your vacation, it doesn't mean you've gained fat. It's likely water weight, according to a dietician.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...

Nearly 70% of adults in Indiana are classified as overweight or obese, contributing to a broader health crisis in the United ...

Viking (VKTX) is in the midst of a phase 2a dosing trial of its oral obesity drug VK2735, with a data readout expected in the second half of the year. The company is expected to launch a phase 3 trial ...

In an Instagram post on0, Rujuta Diwekar shared the importance of achieving sustainable weight loss and prioritising overall ...

NYSE:ALUR) Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity ...

People with higher body mass indexes say they're relieved by experts' new guidance to downplay the use of BMI in diagnosing people with weight problems or obesity.

GPs should not prescribe tirzepatide for weight loss until advised to do so by their local ICB, NHS England has said.

The past few years have been a roller coaster ride for M&A in pharma and biotech. After the highs of the pandemic came ...

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...